20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T20504 | Alanylphenylalanine | NSC89630,Ala-phe,H-Ala-Phe-OH,NSC 89630,L-Alanyl-L-phenylalanine,NSC-89630 | Endogenous Metabolite |
Alanylphenylalanine (Ala-phe) is a compound isolated from the brainstem of calves. | |||
T40490 | Phenylalanylalanine | H-Phe-Ala-OH | Others |
Phenylalanylalanine (H-Phe-Ala-OH) (H-Phe-Ala-OH) is a dipeptide resulting from the fusion of phenylalanine and alanine. It is formed during incomplete protein digestion or catabolism [1]. | |||
TN6428 | Cyclo(Ala-Phe) | ||
Cyclo(Phe-Ala) displays significant anti-diatom activity with the inhibitory rate of 50% at the concentration of 50 microg/mL. | |||
T31630 | Enkephalinamide-met, ala(2)-(penta-F-phe)(4)- | ||
Enkephalinamide-met, ala(2)-(penta-F-phe)(4)- is a biochemical. | |||
T17387 | Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP | Others | |
Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP is a cleavable linker utilized in the synthesis of antibody-drug conjugates (ADCs), which are innovative therapeutic agents that combine the targeting ability of antibodies with potent cy... | |||
T78407 | Suc-Ala-Ala-Phe-AMC | ||
Suc-Ala-Ala-Phe-AMC, a fluorogenic chymotrypsin substrate hydrolyzable by endopeptidase, has applications in vivo for assaying the acrosome reaction and in vitro for enzyme assays [1] [2] [3]. | |||
T78432 | Suc-AAPF-pNA | Suc-Ala-Ala-Pro-Phe-pNA | |
Suc-AAPF-pNA (Suc-Ala-Ala-Pro-Phe-pNA), a chromogenic p-nitroanilide (pNA) substrate, exhibits a Km of 1.7 mM and is utilized for assessing both free and membrane-bound cathepsin G in human neutrophils [1]. | |||
T76621 | Suc-Ala-Ala-Pro-Phe-SBzl | ||
Suc-Ala-Ala-Pro-Phe-SBzl serves as a substrate for rat intestinal mast cell protease (RMCP I), rat skeletal muscle mast cell protease (RMCP II), and Chymotrypsin. Additionally, it undergoes hydrolysis by glycine (R208G) ... | |||
T34023 | Phenylalanyl-prolyl-alanine | Phe-pro-ala | |
Phenylalanyl-prolyl-alanine is a neutral tripeptide. | |||
T81817 | Met-Arg-Phe-Ala | ||
Met-Arg-Phe-Ala, a peptide, serves as a potent competitive inhibitor of enkephalin-generating endopeptidase (EGE) and is utilized in neurological disease research [1]. | |||
T80104 | Z-Phe-Ala-diazomethylketone | PADK | |
Z-Phe-Ala-diazomethylketone directly binds to Aβ42 monomers and small oligomers, effectively inhibiting the formation of Aβ42 dodecamers and preventing Aβ42 fibrillogenesis in solution. This compound holds potential for ... | |||
TP2341 | Hexapeptide-11 | Peptamide 6,Fvapfp,Phe-val-ala-pro-phe-pro | |
Hexapeptide-11 is a novel proteostasis network modulator in human diploid fibroblasts. | |||
T34235 | R 487 | R-487,Asp-ser-phe-phe-beta-ala-leu-met-NH2,R487 | |
R 487 is a bioactive chemical. | |||
T81822 | MeOSuc-AAPF-CMK | MeOSuc-Ala-Ala-Pro-Phe-CH₂Cl | |
MeOSuc-AAPF-CMK (MeOSuc-Ala-Ala-Pro-Phe-CH2Cl) is a potent inhibitor of the enzyme proteinase K [1]. | |||
TP1261 | Alexamorelin Met 1 | (D-Mrp)-Ala-Trp-(D-Phe) | |
Alexamorelin Met 1 is one of the metabolites of alexamorelin. The heptapeptide Ala-His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2 (Alexamorelin) is a synthetic molecule which inhibits growth hormone secretagogue binding in vit... | |||
T32840 | Locustakinin | Ala-phe-ser-ser-trp-gly-NH2,Lomk peptide,Locustakinn | |
Locustakinin is a myotropic peptide. | |||
T76298 | D-Ala-Gly-Phe-Met-NH2 | ||
D-Ala-Gly-Phe-Met-NH2, an opioid peptide, is a potent opiate δ-receptor agonist [1] . | |||
T76622 | Suc-Ala-Leu-Pro-Phe-pNA | ||
Suc-Ala-Leu-Pro-Phe-pNA (Suc-ALPF-pNA), a substrate for FK-506 binding protein (FKBP) [1], showcases the intricate interactions necessary for specific biochemical assays. | |||
TP2478 | WT-1 A1 | Tyr-Met-Phe-Pro-agn-Ala-Pro-Tyr-Leu | |
WT-1 A1 is an attractive target for immunotherapy in patients with pancreatic adenocarcinoma. | |||
TP2480 | Locustamyotropin | Lom-MT,Locustamyotropin I,Lom MT,LomMT,Gly-ala-val-pro-ala-ala-gln-phe-ser-pro-arg-leu-NH2 | |
Locustamyotropin is a novel peptide isolated from Leucophae maderae; stimulates the spontaneous contractions of the hindgut of Leucophaea maderae. |